As expected, SS treatment significantly reduced the binding of EV70, which uses α2,3-linked SA as a receptor, but had no effect on the binding or infection of α2,6-linked SA-dependent FCV or DAF-dependent CVB3 (Fig. 4B and D). Here, CD55 is linked to infection.